Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04VLI
|
||||
Former ID |
DNC004900
|
||||
Drug Name |
4-(2-Hydroxy-ethyl)-benzenesulfonamide
|
||||
Synonyms |
4-(2-hydroxyethyl)benzenesulfonamide
|
||||
Indication | Discovery agent | Investigative | [529948] | ||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C1=CC(=CC=C1CCO)S(=O)(=O)N
|
||||
InChI |
1S/C8H11NO3S/c9-13(11,12)8-3-1-7(2-4-8)5-6-10/h1-4,10H,5-6H2,(H2,9,11,12)
|
||||
InChIKey |
RYKHXKKLCRPAJP-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Carbonic anhydrase XII | Target Info | Inhibitor | [527407] | |
Carbonic anhydrase II | Target Info | Inhibitor | [531031] | ||
Carbonic anhydrase XIV | Target Info | Inhibitor | [527654] | ||
Carbonic anhydrase VI | Target Info | Inhibitor | [529948] | ||
Carbonic anhydrase IX | Target Info | Inhibitor | [529948] | ||
Carbonic anhydrase | Target Info | Inhibitor | [529948] | ||
Pathway Interaction Database | HIF-1-alpha transcription factor network | ||||
Reactome | Reversible hydration of carbon dioxideR-HSA-1237044:Erythrocytes take up carbon dioxide and release oxygen | ||||
Erythrocytes take up oxygen and release carbon dioxide | |||||
Reversible hydration of carbon dioxideR-HSA-1475029:Reversible hydration of carbon dioxideR-HSA-1475029:Reversible hydration of carbon dioxideR-HSA-1234158:Regulation of gene expression by Hypoxia-inducible Factor | |||||
Reversible hydration of carbon dioxide | |||||
WikiPathways | Reversible Hydration of Carbon Dioxide | ||||
miR-targeted genes in muscle cell - TarBase | |||||
miR-targeted genes in leukocytes - TarBase | |||||
miR-targeted genes in epithelium - TarBaseWP2770:Reversible Hydration of Carbon Dioxide | |||||
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes | |||||
Uptake of Oxygen and Release of Carbon Dioxide by ErythrocytesWP2770:Reversible Hydration of Carbon DioxideWP2770:Reversible Hydration of Carbon DioxideWP2877:Vitamin D Receptor Pathway | |||||
Regulation of Hypoxia-inducible Factor (HIF) by Oxygen | |||||
References | |||||
Ref 527407 | Bioorg Med Chem Lett. 2005 Feb 15;15(4):963-9.Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?. | ||||
Ref 527654 | Bioorg Med Chem Lett. 2005 Sep 1;15(17):3828-33.Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. | ||||
Ref 529948 | J Med Chem. 2009 Feb 12;52(3):646-54.Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV. | ||||
Ref 531031 | Bioorg Med Chem. 2010 Aug 1;18(15):5498-503. Epub 2010 Jun 22.Mutation of Phe91 to Asn in human carbonic anhydrase I unexpectedly enhanced both catalytic activity and affinity for sulfonamide inhibitors. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.